E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis

被引：0
作者：
Jingxuan Li
Jiying Wang
Yanping Wang
Xueyan Zhao
Tao Su
机构：
[1] Shandong Academy of Agricultural Sciences,Shandong Provincial Key Laboratory of Animal Disease Control and Breeding, Institute of Animal Science and Veterinary Medicine
[2] Shandong University,Medical Integration and Practice Center, Cheeloo College of Medicine
来源：
Clinical Epigenetics | / 15卷
关键词：
lncRNA; Super-enhancer; Hepatocellular carcinoma; E2F1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 268 条
  • [1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
  • [2] Ferlay J(2018)Hepatocellular carcinoma Lancet 391 1301-1314
  • [3] Siegel RL(2016)Hepatocellular carcinoma Nat Rev Dis Primers 2 16018-643
  • [4] Laversanne M(2017)Transcriptional addiction in cancer Cell 168 629-177
  • [5] Soerjomataram I(2017)Functional enhancers as master regulators of tissue-specific gene regulation and cancer development Mol Cells 40 169-284
  • [6] Jemal A(2012)Enhancers as information integration hubs in development: lessons from genomics Trends Genet 28 276-947
  • [7] Bray F(2013)Super-enhancers in the control of cell identity and disease Cell 155 934-283
  • [8] Forner A(2011)A unique chromatin signature uncovers early developmental enhancers in humans Nature 470 279-1139
  • [9] Reig M(2014)CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer Cell 159 1126-138
  • [10] Bruix J(2019)Super-enhancers in cancer Pharmacol Ther 199 129-11062
12345678910